<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Protein intake in patients on maintenance hemodialysis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Protein intake in patients on maintenance hemodialysis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Protein intake in patients on maintenance hemodialysis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Wajeh Y Qunibi, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Steve J Schwab, MD, FACP, FASN</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Eric N Taylor, MD, MSc, FASN</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Apr 03, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Low dietary protein intake is common among patients on hemodialysis [<a href="#rid1">1</a>], and markers of inadequate protein intake are associated with a wide variety of adverse outcomes, including death [<a href="#rid2">2-5</a>]. Therefore, it is important to monitor protein intake along with other measures of nutrition in these patients [<a href="#rid6">6</a>].</p><p>It is difficult to directly measure protein intake. A method that is commonly used to estimate protein intake is to measure the rate of increase in serum urea nitrogen levels between two hemodialysis treatments. This indirect marker of protein intake is referred to as the protein equivalent of nitrogen appearance (PNA) or protein catabolic rate (PCR). The PCR is used to assess dietary protein intake in patients on dialysis.</p><p>This topic reviews the use of the PCR for the estimation of protein intake and recommendations for optimal protein intake for patients on dialysis. The assessment of overall nutritional status, protein-energy wasting (PEW) syndrome, and treatment of malnutrition among patients on hemodialysis is discussed elsewhere.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/1850.html" rel="external">"Assessment of nutritional status in patients on hemodialysis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/1856.html" rel="external">"Pathogenesis and treatment of malnutrition in patients on maintenance hemodialysis"</a>.)</p><p></p><p>Optimal protein intake among patients on peritoneal dialysis is discussed elsewhere.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/1855.html" rel="external">"Nutritional status and protein intake in patients on peritoneal dialysis"</a>.)</p><p></p><p class="headingAnchor" id="H187128200"><span class="h1">OVERVIEW</span><span class="headingEndMark"> — </span>The protein catabolic rate (PCR) reflects the amount of protein that is catabolized in excess of the amount of protein that is synthesized per day. In a person who is in steady state (ie, neither catabolic nor anabolic), the PCR reflects dietary protein intake [<a href="#rid7">7</a>]. </p><p class="headingAnchor" id="H98459038"><span class="h2">Calculation</span><span class="headingEndMark"> — </span>The PCR is calculated from the interdialytic appearance of urea in body fluids. The interdialytic appearance of urea is determined by measuring the blood urea nitrogen (BUN) at the end of one dialysis session and just prior to the start of the next dialysis session. Among patients who have low BUN, measuring the change in BUN between dialysis sessions (ie, the PCR) distinguishes adequate dialysis as a cause of low BUN from poor intake resulting from inadequate dialysis.</p><p>As an example, a low predialysis BUN could represent either a well-nourished patient who is adequately dialyzed or a patient who is malnourished due to poor appetite from inadequate dialysis. The PCR will distinguish between these possibilities.</p><p>The PCR is expressed as g per day. Usually, the PCR is normalized to the patient’s body weight (nPCR), which is expressed as g/kg per day.</p><p>The PCR in patients treated with hemodialysis is calculated by various urea kinetic modeling software programs. If a computer program is not available, the following simple formula will give a good estimate of the nPCR [<a href="#rid8">8</a>]:</p><div class="formulaContainer"><div class="formula"><p>                                                      (0.036  x  ID rise in BUN  x  24)<br/>  nPCR, in g/kg per day  =  0.22 + —————————————————<br/>                                                                  ID interval (hours)</p></div></div><p>where the interdialytic (ID) rise in BUN is expressed in mg/dL. If, for example, the interdialytic rise in BUN is 50 mg/dL (18 mmol/L) and there are 44 hours from the end of one dialysis to the beginning of the next, then:</p><div class="formulaContainer"><div class="formula"><p>  nPCR  =  0.22 + ([0.036  x  50  x  24]  ÷  44)  =  1.20 g/kg per day</p></div></div><p>The nPCR can also be calculated from the Kt/V (an index of urea removal during dialysis) and the average BUN [<a href="#rid9">9</a>].</p><p>Among patients with residual kidney function, total urea lost in the urine must also be measured from urine collected during the interdialytic period. Using this measurement, the following term is added to the equation for nPCR:</p><div class="formulaContainer"><div class="formula"><p>       Urinary urea nitrogen (g)  x  150<br/>  + ———————————————————<br/>       ID interval (hours)  x  weight (kg)</p></div></div><p>where the urinary urea nitrogen is all of the urea nitrogen excreted in a urine collection obtained from the end of one dialysis to the beginning of the next (ie, in the interdialytic interval).</p><p>The importance of residual renal urea clearance was shown in a study of 36,757 patients on incident hemodialysis, in which an nPCR variable was used to account for residual renal clearance [<a href="#rid4">4</a>]. Higher baseline renal urea clearance-corrected nPCR and a greater increase in renal urea clearance-corrected nPCR over time were independently associated with higher serum albumin levels and lower all-cause mortality. The authors concluded that nPCR may be underestimated when not accounting for renal urea clearance and, compared with the conventional nPCR, renal urea clearance–corrected nPCR may be a better marker of mortality.</p><p class="headingAnchor" id="H98458920"><span class="h2">Relationship between dialysis adequacy and protein catabolic rate</span><span class="headingEndMark"> — </span>The PCR varies directly with the Kt/V, a measure of dialysis adequacy [<a href="#rid5">5</a>]. (See  <a class="medical medical_review" href="/z/d/html/1836.html" rel="external">"Prescribing and assessing adequate hemodialysis"</a>.)</p><p>Patients who receive an inadequate amount of dialysis, as demonstrated by a low Kt/V, are often uremic and anorexic. As a result, they have a low protein intake and low PCR. Delivery of more dialysis as assessed by a higher Kt/V often improves appetite and increases protein intake, leading to higher PCR. As examples:</p><p class="bulletIndent1"><span class="glyph">●</span>In a study of a small group of patients on hemodialysis, the intensity of dialysis was increased by increasing dialysis time, blood flow, and/or membrane surface area [<a href="#rid10">10</a>]. As the Kt/V rose from 0.82 to 1.32 over a three-month period, there was a concurrent increase in nPCR from 0.81 to 1.02 g/kg per day. A second group in which the dialysis regimen was unchanged had no increase in either Kt/V or nPCR.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In another report, converting 13 patients from conventional dialysis (three times, four hours each week) to three times per week nocturnal dialysis (three times, eight hours each week) increased the Kt/V from 1.87 to 2.7 and the nPCR from 1.39 to 2.25 g/kg per day at 12 months [<a href="#rid11">11</a>].</p><p></p><p>The association between a low normalized protein nitrogen appearance (nPNA) and outcome could be attributable to the adverse effects of low Kt/V. However, one study reported that the amount of daily protein intake, expressed as nPCR, has an independent effect on morbidity and mortality in patients on hemodialysis whose dialysis dose was considered adequate [<a href="#rid5">5</a>].</p><p class="headingAnchor" id="H23442038"><span class="h2">Limitations of protein catabolic rate</span><span class="headingEndMark"> — </span>The use of PCR to estimate protein intake has a number of limitations [<a href="#rid12">12,13</a>]. These include the following:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patients must be in neutral nitrogen balance</strong> – The PCR reflects protein intake only in patients in neutral nitrogen balance (ie, steady state). Many patients on dialysis are not in neutral nitrogen balance. The PCR overestimates dietary protein intake in patients who are catabolic, such as those with active inflammation. This is because there is an increase in endogenous nitrogen breakdown in such patients, which is reflected in the PCR. A rapid increase in PCR or a PCR over 1.4 g/kg/day is likely to be attributed to an increase in catabolic rate during infection or inflammation, especially if the PCR increase occurs in the setting of loss of weight and decline in serum albumin and creatinine [<a href="#rid14">14</a>].</p><p></p><p class="bulletIndent1">Conversely, the PCR underestimates dietary protein intake in patients who are anabolic, such as those recovering from infection, growing children, or individuals in the last trimester of pregnancy. This is because dietary protein is utilized for build-up of new body protein pools and does not contribute to the appearance of nitrogen [<a href="#rid13">13</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>PCR overestimates dietary protein intake when intake is low</strong> – The PCR may overestimate dietary protein intake when the protein intake is less than 1 g/kg/day, possibly due to endogenous protein catabolism [<a href="#rid13">13</a>]. One study showed that at progressively greater levels of C-reactive protein (CRP), serum albumin concentration decreased even if nPCR values were high [<a href="#rid15">15</a>]. The same authors also showed that nPCR may overestimate dietary protein intake because of endogenous nitrogen breakdown during inflammation [<a href="#rid16">16</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>PCR fluctuates rapidly in response to daily protein intake</strong> – As a result of rapid fluctuations in PCR following changes in protein intake, individual values may reflect the most recent protein intake and not the patient's usual diet [<a href="#rid13">13</a>]. In one study of 50 patients, for example, three measurements from a single individual were required to obtain a PCR with an error of less than 10 percent [<a href="#rid17">17</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>The PCR underestimates dietary protein intake by a variable amount</strong> – The PCR accurately reflects the dietary protein intake only if the method used to calculate the PCR includes all the body nitrogen output, including losses into dialysate [<a href="#rid12">12,18</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>PCR normalized to body weight may be misleading in patients with obesity, malnutrition, or edema</strong> – Normalization of PCR to body weight may be misleading in individuals with obesity, malnutrition, or edema because body weight can vary significantly over short periods of time. In addition, the nPCR can overestimate protein intake in malnourished patients and older adults with muscle wasting and underestimate protein intake in patients with increased fat mass. To address these limitations, it has been suggested that PCR should be normalized to lean body weight, which would directly couple PCR to changes in protein or nitrogen reserve [<a href="#rid19">19</a>].</p><p></p><p class="headingAnchor" id="H187128245"><span class="h1">TARGET PROTEIN CATABOLIC RATE</span><span class="headingEndMark"> — </span>The optimal target normalized protein catabolic rate (nPCR) is &gt;1.4 g/kg/day. However, this target is difficult to achieve. We suggest a minimum target nPCR of 1.2 g/kg/day. This is consistent with both the American Kidney Disease Outcomes Quality Initiative (KDOQI) clinical practice guidelines and the European Best Practice Guidelines on hemodialysis [<a href="#rid7">7,20</a>].</p><p>The recommendations also indicate that one-half of the daily protein intake should be of high biological value (ie, animal based) proteins. However, patients on dialysis who consume vegetarian diets have also been able to attain an adequate amount of protein intake, estimated at 1.1 to 1.25 g/kg/day of protein [<a href="#rid21">21</a>]. Besides being adequate, a plant-based protein diet may provide additional benefits including better control of hypertension, hyperphosphatemia, and metabolic acidosis and reduced protein-bound uremic toxins such as indoxyl sulfate and p-cresyl sulfate [<a href="#rid21">21,22</a>].</p><p>Multiple studies have suggested that, compared with lower values, an nPCR between 1.0 and 1.4 is associated with lower mortality [<a href="#rid23">23-25</a>]. Perhaps the best data are from a retrospective, two-year study that evaluated time-varying dietary protein intake and survival among nearly 54,000 patients on hemodialysis [<a href="#rid25">25</a>]. The best survival was noted with nPCR levels between 1.0 and 1.4 g/kg/day. However, a review of dietary protein intake studies in patients on dialysis found that a majority of the studies published after the KDOQI guidelines became available still indicated suboptimal dietary protein intake in patients on hemodialysis [<a href="#rid26">26</a>].</p><p class="headingAnchor" id="H23442919"><span class="h1">MONITORING AND INTERVENTION</span><span class="headingEndMark"> — </span>Patients on hemodialysis have a high dietary protein requirement but often consume less than 1 g/kg/day of protein [<a href="#rid27">27</a>]. In order to avoid malnutrition and its accompanying poor outcomes, the protein catabolic rate (PCR) should be measured monthly along with the Kt/V and with other assessments of nutritional status. (See  <a class="medical medical_review" href="/z/d/html/1850.html" rel="external">"Assessment of nutritional status in patients on hemodialysis", section on 'Laboratory assessment'</a>.)</p><p>The management of patients on hemodialysis with inadequate protein intake, including patients with protein-energy wasting (PEW) syndrome, is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/1856.html" rel="external">"Pathogenesis and treatment of malnutrition in patients on maintenance hemodialysis", section on 'Management of PEW'</a>.)</p><p class="headingAnchor" id="H192306526"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Estimation of protein intake</strong> – The protein catabolic rate (PCR), also called the protein equivalent of nitrogen appearance (PNA), can be used to assess dietary protein intake in patients on hemodialysis who are in a steady state. The PCR is used along with many other markers of nutritional status in patients on hemodialysis. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Calculation of protein catabolic rate (PCR)</strong> – The PCR is usually expressed as g/kg body weight per day, a parameter that is also called the normalized PCR (nPCR). A simple calculation of nPCR requires only the pre- and post-blood urea nitrogen (BUN) and the calculated Kt/V obtained during a single dialysis session. Adjustments for unmeasured urinary urea losses must be made to the calculation if the patient has significant residual kidney function. (See <a class="local">'Calculation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dialysis adequacy and PCR</strong> – The nPCR varies directly with the Kt/V, which is a marker of dialysis adequacy. As dialysis adequacy increases, protein intake (and thus nPCR) generally increases. However, the nPCR is independently associated with the morbidity and mortality of patients on hemodialysis who are adequately dialyzed as expressed by Kt/V &gt;1.2. (See <a class="local">'Relationship between dialysis adequacy and protein catabolic rate'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Target PCR</strong> – The optimal target nPCR is &gt;1.4 g/kg per day. However, this target is difficult to achieve. We target a goal nPCR of ≥1.2 g/kg per day. (See <a class="local">'Target protein catabolic rate'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Monitoring of PCR</strong> – The PCR should be measured monthly along with other measures of nutritional adequacy. Interventions should be directed to help maintain a minimum PCR of 1.2 g/kg per day. (See <a class="local">'Monitoring and intervention'</a> above.)</p><p></p><p class="headingAnchor" id="H187128845"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Robert E Cronin, MD, and William L Henrich, MD, MACP, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Rocco MV, Paranandi L, Burrowes JD, et al. Nutritional status in the HEMO Study cohort at baseline. Hemodialysis. Am J Kidney Dis 2002; 39:245.</a></li><li><a class="nounderline abstract_t">MacLaughlin HL, Friedman AN, Ikizler TA. Nutrition in Kidney Disease: Core Curriculum 2022. Am J Kidney Dis 2022; 79:437.</a></li><li><a class="nounderline abstract_t">Hasegawa J, Kimachi M, Kurita N, et al. The Normalized Protein Catabolic Rate and Mortality Risk of Patients on Hemodialysis by Frailty Status: The Japanese Dialysis Outcomes and Practice Pattern Study. J Ren Nutr 2020; 30:535.</a></li><li><a class="nounderline abstract_t">Eriguchi R, Obi Y, Streja E, et al. Longitudinal Associations among Renal Urea Clearance-Corrected Normalized Protein Catabolic Rate, Serum Albumin, and Mortality in Patients on Hemodialysis. Clin J Am Soc Nephrol 2017; 12:1109.</a></li><li><a class="nounderline abstract_t">Kalantar-Zadeh K, Supasyndh O, Lehn RS, et al. Normalized protein nitrogen appearance is correlated with hospitalization and mortality in hemodialysis patients with Kt/V greater than 1.20. J Ren Nutr 2003; 13:15.</a></li><li><a class="nounderline abstract_t">Ikizler TA, Burrowes JD, Byham-Gray LD, et al. KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update. Am J Kidney Dis 2020; 76:S1.</a></li><li><a class="nounderline abstract_t">Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation. Am J Kidney Dis 2000; 35:S1.</a></li><li><a class="nounderline abstract_t">Jindal KK, Goldstein MB. Urea kinetic modeling in chronic hemodialysis: Benefits, problems, and practical solutions. Semin Dial 1988; 1:82.</a></li><li><a class="nounderline abstract_t">Lightfoot BO, Caruana RJ, Mulloy LL, Fincher ME. Simple formula for calculating normalized protein catabolic rate (NPCR) in hemodialysis (HD) patients (abstract). J Am Soc Nephrol 1993; 4:363.</a></li><li><a class="nounderline abstract_t">Lindsay RM, Spanner E, Heidenheim RP, et al. Which comes first, Kt/V or PCR--chicken or egg? Kidney Int Suppl 1992; 38:S32.</a></li><li><a class="nounderline abstract_t">David S, Kümpers P, Eisenbach GM, et al. Prospective evaluation of an in-centre conversion from conventional haemodialysis to an intensified nocturnal strategy. Nephrol Dial Transplant 2009; 24:2232.</a></li><li><a class="nounderline abstract_t">Kim Y, Molnar MZ, Rattanasompattikul M, et al. Relative contributions of inflammation and inadequate protein intake to hypoalbuminemia in patients on maintenance hemodialysis. Int Urol Nephrol 2013; 45:215.</a></li><li><a class="nounderline abstract_t">Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation. Am J Kidney Dis 2000; 35:S1.</a></li><li><a class="nounderline abstract_t">Lukowsky LR, Kheifets L, Arah OA, et al. Nutritional predictors of early mortality in incident hemodialysis patients. Int Urol Nephrol 2014; 46:129.</a></li><li><a class="nounderline abstract_t">Kaysen GA, Dubin JA, Müller HG, et al. Levels of alpha1 acid glycoprotein and ceruloplasmin predict future albumin levels in hemodialysis patients. Kidney Int 2001; 60:2360.</a></li><li><a class="nounderline abstract_t">Kaysen GA, Dubin JA, Müller HG, et al. Relationships among inflammation nutrition and physiologic mechanisms establishing albumin levels in hemodialysis patients. Kidney Int 2002; 61:2240.</a></li><li><a class="nounderline abstract_t">Kloppenburg WD, Stegeman CA, Hooyschuur M, et al. Assessing dialysis adequacy and dietary intake in the individual hemodialysis patient. Kidney Int 1999; 55:1961.</a></li><li><a class="nounderline abstract_t">Uribarri J. Protein catabolic rate may underestimate dietary protein intake in hemodialysis patients. Nephron 1999; 82:97.</a></li><li><a class="nounderline abstract_t">Canaud B, Leblanc M, Garred LJ, et al. Protein catabolic rate over lean body mass ratio: a more rational approach to normalize the protein catabolic rate in dialysis patients. Am J Kidney Dis 1997; 30:672.</a></li><li><a class="nounderline abstract_t">Tattersall J, Martin-Malo A, Pedrini L, et al. EBPG guideline on dialysis strategies. Nephrol Dial Transplant 2007; 22 Suppl 2:ii5.</a></li><li><a class="nounderline abstract_t">Kandouz S, Mohamed AS, Zheng Y, et al. Reduced protein bound uraemic toxins in vegetarian kidney failure patients treated by haemodiafiltration. Hemodial Int 2016; 20:610.</a></li><li><a class="nounderline abstract_t">Joshi S, Shah S, Kalantar-Zadeh K. Adequacy of Plant-Based Proteins in Chronic Kidney Disease. J Ren Nutr 2019; 29:112.</a></li><li><a class="nounderline abstract_t">Laird NM, Berkey CS, Lowrie EG. Modeling success or failure of dialysis therapy: the National Cooperative Dialysis Study. Kidney Int Suppl 1983; :S101.</a></li><li><a class="nounderline abstract_t">Segall L, Mardare NG, Ungureanu S, et al. Nutritional status evaluation and survival in haemodialysis patients in one centre from Romania. Nephrol Dial Transplant 2009; 24:2536.</a></li><li><a class="nounderline abstract_t">Shinaberger CS, Kilpatrick RD, Regidor DL, et al. Longitudinal associations between dietary protein intake and survival in hemodialysis patients. Am J Kidney Dis 2006; 48:37.</a></li><li><a class="nounderline abstract_t">Therrien M, Byham-Gray L, Beto J. A Review of Dietary Intake Studies in Maintenance Dialysis Patients. J Ren Nutr 2015; 25:329.</a></li><li><a class="nounderline abstract_t">Shinaberger CS, Greenland S, Kopple JD, et al. Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr 2008; 88:1511.</a></li></ol></div><div id="topicVersionRevision">Topic 1841 Version 24.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11840364" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Nutritional status in the HEMO Study cohort at baseline. Hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34862042" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Nutrition in Kidney Disease: Core Curriculum 2022.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32122750" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : The Normalized Protein Catabolic Rate and Mortality Risk of Patients on Hemodialysis by Frailty Status: The Japanese Dialysis Outcomes and Practice Pattern Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28490436" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Longitudinal Associations among Renal Urea Clearance-Corrected Normalized Protein Catabolic Rate, Serum Albumin, and Mortality in Patients on Hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12563619" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Normalized protein nitrogen appearance is correlated with hospitalization and mortality in hemodialysis patients with Kt/V greater than 1.20.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32829751" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10895784" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Urea kinetic modeling in chronic hemodialysis: Benefits, problems, and practical solutions</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Simple formula for calculating normalized protein catabolic rate (NPCR) in hemodialysis (HD) patients (abstract)</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1405378" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Which comes first, Kt/V or PCR--chicken or egg?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19208770" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Prospective evaluation of an in-centre conversion from conventional haemodialysis to an intensified nocturnal strategy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22528583" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Relative contributions of inflammation and inadequate protein intake to hypoalbuminemia in patients on maintenance hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10895784" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23703546" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Nutritional predictors of early mortality in incident hemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11737611" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Levels of alpha1 acid glycoprotein and ceruloplasmin predict future albumin levels in hemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12028466" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Relationships among inflammation nutrition and physiologic mechanisms establishing albumin levels in hemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10231460" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Assessing dialysis adequacy and dietary intake in the individual hemodialysis patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10610493" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Protein catabolic rate may underestimate dietary protein intake in hemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9370183" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Protein catabolic rate over lean body mass ratio: a more rational approach to normalize the protein catabolic rate in dialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17507427" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : EBPG guideline on dialysis strategies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27044443" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Reduced protein bound uraemic toxins in vegetarian kidney failure patients treated by haemodiafiltration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30122652" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Adequacy of Plant-Based Proteins in Chronic Kidney Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6345890" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Modeling success or failure of dialysis therapy: the National Cooperative Dialysis Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19297358" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Nutritional status evaluation and survival in haemodialysis patients in one centre from Romania.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16797385" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Longitudinal associations between dietary protein intake and survival in hemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25592493" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : A Review of Dietary Intake Studies in Maintenance Dialysis Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19064510" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
